Opus Genetics Inc
NASDAQ:IRD
Opus Genetics Inc
NASDAQ:IRD
Price:
3.64
USD
5.51%
Market Cap:
$251m
Relative Value
The Relative Value of one
IRD
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.64 USD,
Opus Genetics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IRD Relative Value
HIDDEN
Multiples Across Competitors
IRD Competitors Multiples
Opus Genetics Inc Competitors
Opus Genetics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Opus Genetics Inc
NASDAQ:IRD
|
234.9m USD | 16 | -3.4 | -5.9 | -5.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
989.2B USD | 15.1 | 47.6 | 32.1 | 34.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
593.2B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
294.8B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.1B GBP | 5.4 | 31.1 | 17.2 | 24.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
248.7B CHF | 5.7 | 22.9 | 14.1 | 18.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
310.9B USD | 4.7 | 16.8 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.4 | 7.7 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.9B USD | 2.6 | 17.5 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
